Editor’s Selections: Direct-to-order genomes, anti-depressants, and sexuality
November 4th, 2009 Editor's Selections 2 Comments
Travis Saunders selects several notable posts each week from Health and Clinical Research. He blogs at Obesity Panacea.
- Several companies now offer direct-to-consumer genetic testing. Is it worth it? Brainblogger discusses the likelihood that this information will be useful to you, or your physician.
- What is the best anti-depressant? Apparently that answer depends on which meta-analysis you choose to believe. Neuroskeptic chronicles the fierce debate which has resulted among researchers.
- Can a stroke or brain tumor affect your sexual preferences? Neurocritic gives a fascinating overview of the evidence.
- Transcranial magnetic stimulation for depression: not so effective, but FDA approved. A terrific (and ironically depressing) post by Clinical Psychology and Psychiatry: A Closer Look.
